Click for best price
HealthcareAcquired Infection Market Size, Share 2022
The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.
This report contains market size and forecasts of Healthcare-Acquired Infection in Global, including the following market information:
Global top five companies in 2021 (%)
The global Healthcare-Acquired Infection market was valued at 24880 million in 2021 and is projected to reach US$ 40490 million by 2028, at a CAGR of 7.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmaceutical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Healthcare-Acquired Infection include Pfizer, Novartis, Roche, Sanofi, Abbott, BD and Hologic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare-Acquired Infection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare-Acquired Infection Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Healthcare-Acquired Infection Market Segment Percentages, by Type, 2021 (%)
- Pharmaceutical Treatment
- Environment Treatment
- Medical Devices Management
Global Healthcare-Acquired Infection Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Healthcare-Acquired Infection Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinics
- Ambulatory Surgery Centers
- Others
Global Healthcare-Acquired Infection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Healthcare-Acquired Infection Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Healthcare-Acquired Infection revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Healthcare-Acquired Infection revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Roche
- Sanofi
- Abbott
- BD
- Hologic
| Report Attributes |
Report Details |
| Report Title |
Healthcare-Acquired Infection Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Healthcare-Acquired Infection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare-Acquired Infection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare-Acquired Infection Overall Market Size
2.1 Global Healthcare-Acquired Infection Market Size: 2021 VS 2028
2.2 Global Healthcare-Acquired Infection Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare-Acquired Infection Players in Global Market
3.2 Top Global Healthcare-Acquired Infection Companies Ranked by Revenue
3.3 Global Healthcare-Acquired Infection Revenue by Companies
3.4 Top 3 and Top 5 Healthcare-Acquired Infection Companies in Global Market, by Revenue in 2021
3.5 Global Companies Healthcare-Acquired Infection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare-Acquired Infection Players in Global Market
3.6.1 List of Global Tier 1 Healthcare-Acquired Infection Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare-Acquired Infection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Healthcare-Acquired Infection Market Size Markets, 2021 & 2028
4.1.2 Pharmaceutical Treatment
4.1.3 Environment Treatment
4.1.4 Medical Devices Management
4.2 By Type - Global Healthcare-Acquired Infection Revenue & Forecasts
4.2.1 By Type - Global Healthcare-Acquired Infection Revenue, 2017-2022
4.2.2 By Type - Global Healthcare-Acquired Infection Revenue, 2023-2028
4.2.3 By Type - Global Healthcare-Acquired Infection Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Healthcare-Acquired Infection Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Ambulatory Surgery Centers
5.1.5 Others
5.2 By Application - Global Healthcare-Acquired Infection Revenue & Forecasts
5.2.1 By Application - Global Healthcare-Acquired Infection Revenue, 2017-2022
5.2.2 By Application - Global Healthcare-Acquired Infection Revenue, 2023-2028
5.2.3 By Application - Global Healthcare-Acquired Infection Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Healthcare-Acquired Infection Market Size, 2021 & 2028
6.2 By Region - Global Healthcare-Acquired Infection Revenue & Forecasts
6.2.1 By Region - Global Healthcare-Acquired Infection Revenue, 2017-2022
6.2.2 By Region - Global Healthcare-Acquired Infection Revenue, 2023-2028
6.2.3 By Region - Global Healthcare-Acquired Infection Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Healthcare-Acquired Infection Revenue, 2017-2028
6.3.2 US Healthcare-Acquired Infection Market Size, 2017-2028
6.3.3 Canada Healthcare-Acquired Infection Market Size, 2017-2028
6.3.4 Mexico Healthcare-Acquired Infection Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Healthcare-Acquired Infection Revenue, 2017-2028
6.4.2 Germany Healthcare-Acquired Infection Market Size, 2017-2028
6.4.3 France Healthcare-Acquired Infection Market Size, 2017-2028
6.4.4 U.K. Healthcare-Acquired Infection Market Size, 2017-2028
6.4.5 Italy Healthcare-Acquired Infection Market Size, 2017-2028
6.4.6 Russia Healthcare-Acquired Infection Market Size, 2017-2028
6.4.7 Nordic Countries Healthcare-Acquired Infection Market Size, 2017-2028
6.4.8 Benelux Healthcare-Acquired Infection Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Healthcare-Acquired Infection Revenue, 2017-2028
6.5.2 China Healthcare-Acquired Infection Market Size, 2017-2028
6.5.3 Japan Healthcare-Acquired Infection Market Size, 2017-2028
6.5.4 South Korea Healthcare-Acquired Infection Market Size, 2017-2028
6.5.5 Southeast Asia Healthcare-Acquired Infection Market Size, 2017-2028
6.5.6 India Healthcare-Acquired Infection Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Healthcare-Acquired Infection Revenue, 2017-2028
6.6.2 Brazil Healthcare-Acquired Infection Market Size, 2017-2028
6.6.3 Argentina Healthcare-Acquired Infection Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Healthcare-Acquired Infection Revenue, 2017-2028
6.7.2 Turkey Healthcare-Acquired Infection Market Size, 2017-2028
6.7.3 Israel Healthcare-Acquired Infection Market Size, 2017-2028
6.7.4 Saudi Arabia Healthcare-Acquired Infection Market Size, 2017-2028
6.7.5 UAE Healthcare-Acquired Infection Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Healthcare-Acquired Infection Major Product Offerings
7.1.4 Pfizer Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Healthcare-Acquired Infection Major Product Offerings
7.2.4 Novartis Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Healthcare-Acquired Infection Major Product Offerings
7.3.4 Roche Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Healthcare-Acquired Infection Major Product Offerings
7.4.4 Sanofi Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.4.5 Sanofi Key News
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Healthcare-Acquired Infection Major Product Offerings
7.5.4 Abbott Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.5.5 Abbott Key News
7.6 BD
7.6.1 BD Corporate Summary
7.6.2 BD Business Overview
7.6.3 BD Healthcare-Acquired Infection Major Product Offerings
7.6.4 BD Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.6.5 BD Key News
7.7 Hologic
7.7.1 Hologic Corporate Summary
7.7.2 Hologic Business Overview
7.7.3 Hologic Healthcare-Acquired Infection Major Product Offerings
7.7.4 Hologic Healthcare-Acquired Infection Revenue in Global Market (2017-2022)
7.7.5 Hologic Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Healthcare-Acquired Infection Market Opportunities & Trends in Global Market
Table 2. Healthcare-Acquired Infection Market Drivers in Global Market
Table 3. Healthcare-Acquired Infection Market Restraints in Global Market
Table 4. Key Players of Healthcare-Acquired Infection in Global Market
Table 5. Top Healthcare-Acquired Infection Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Healthcare-Acquired Infection Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Healthcare-Acquired Infection Revenue Share by Companies, 2017-2022
Table 8. Global Companies Healthcare-Acquired Infection Product Type
Table 9. List of Global Tier 1 Healthcare-Acquired Infection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare-Acquired Infection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Healthcare-Acquired Infection Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Healthcare-Acquired Infection Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Healthcare-Acquired Infection Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Healthcare-Acquired Infection Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Healthcare-Acquired Infection Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Healthcare-Acquired Infection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Healthcare-Acquired Infection Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Healthcare-Acquired Infection Product Offerings
Table 32. Pfizer Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Healthcare-Acquired Infection Product Offerings
Table 35. Novartis Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Healthcare-Acquired Infection Product Offerings
Table 38. Roche Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Healthcare-Acquired Infection Product Offerings
Table 41. Sanofi Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Healthcare-Acquired Infection Product Offerings
Table 44. Abbott Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
Table 45. BD Corporate Summary
Table 46. BD Healthcare-Acquired Infection Product Offerings
Table 47. BD Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
Table 48. Hologic Corporate Summary
Table 49. Hologic Healthcare-Acquired Infection Product Offerings
Table 50. Hologic Healthcare-Acquired Infection Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Healthcare-Acquired Infection Segment by Type in 2021
Figure 2. Healthcare-Acquired Infection Segment by Application in 2021
Figure 3. Global Healthcare-Acquired Infection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Healthcare-Acquired Infection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Healthcare-Acquired Infection Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare-Acquired Infection Revenue in 2021
Figure 8. By Type - Global Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 9. By Application - Global Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 10. By Region - Global Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 11. By Country - North America Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 12. US Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 16. Germany Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 17. France Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 24. China Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 28. India Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 30. Brazil Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Healthcare-Acquired Infection Revenue Market Share, 2017-2028
Figure 33. Turkey Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Healthcare-Acquired Infection Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BD Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hologic Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
